Thiomaltol-Based Organometallic Complexes with 1-Methylimidazole as Leaving Group: Synthesis, Stability, and Biological Behavior-Reference-Cited by-同舟云学术

Thiomaltol-Based Organometallic Complexes with 1-Methylimidazole as Leaving Group: Synthesis, Stability, and Biological Behavior

Published:2016-10-19 Issue:48 Volume:22 Page:17269-17281
ISSN:0947-6539
Container-title:Chemistry - A European Journal
language:en
Short-container-title:Chem. Eur. J.

Author:

Hackl Carmen M.¹,Legina Maria S.¹,Pichler Verena¹,Schmidlehner Melanie¹,Roller Alexander¹,Dömötör Orsolya²³,Enyedy Eva A.²,Jakupec Michael A.¹⁴,Kandioller Wolfgang¹⁴^ORCID,Keppler Bernhard K.¹⁴

Affiliation:

1. Institute of Inorganic Chemistry; University of Vienna; Waehringer Str. 42 1090 Vienna Austria

2. Department of Inorganic and Analytical Chemistry; University of Szeged; Dóm tér 7 6720 Szeged Hungary

3. MTA-SZTE Bioinorganic Chemistry Research Group; University of Szeged; Dóm tér 7 6720 Szeged Hungary

4. Research Platform “Translational Cancer Therapy Research”; University of Vienna; Waehringer Str. 42 1090 Vienna Austria

Publisher

Wiley

Subject

General Chemistry,Catalysis,Organic Chemistry

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/chem.201603206/fullpdf

Reference53 articles.

1. Resistance against novel anticancer metal compounds: Differences and similarities

2. Molecular mode of action of NKP-1339 – a clinically investigated ruthenium-based drug – involves ER- and ROS-related effects in colon carcinoma cell lines

3. The ruthenium compound KP1339 potentiates the anticancer activity of sorafenib in vitro and in vivo

4. Free Exchange across Cells, and Echistatin-Sensitive Membrane Target for the Metastasis Inhibitor NAMI-A (Imidazoliumtrans-Imidazole Dimethyl Sulfoxide Tetrachlororuthenate) on KB Tumor Cells

5. Inhibition of endothelial cell functions and of angiogenesis by the metastasis inhibitor NAMI-A

Cited by 33 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Di-µ-(1-(3-(1H-imidazol-1-yl)propyl)-2-methyl-4-oxo-1,4-dihydropyridin-3-olate)-bis[(η5-pentamethylcyclopentadienyl)iridium(III)] Chloride;Molbank;2024-05-05

2. Overview of the New Bioactive Heterocycles as Targeting Topoisomerase Inhibitors Useful Against Colon Cancer;Anti-Cancer Agents in Medicinal Chemistry;2024-04

3. A Mini Review of Novel Topoisomerase II Inhibitors as Future Anticancer Agents;International Journal of Molecular Sciences;2023-01-28

4. Half-Sandwich Rhodium Complexes with Releasable N-Donor Monodentate Ligands: Solution Chemical Properties and the Possibility for Acidosis Activation;Pharmaceutics;2023-01-20

5. Noncovalent interactions of antitumor cycloplatinated complexes containing trifluoroacetate ligands as the leaving group with bovine serum albumin. Implications for drug design;New Journal of Chemistry;2023